Success Stories: We Guided a Medical Device Expert from China to NIW Approval, Without an RFE

 

Client’s Testimonial:

“Thank you for your assistance with the petition.”


On November 25th, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Product Development Engineer in the Field of Medical Devices (Approval Notice).


General Field: Medical Devices

Position at the Time of Case Filing: Product Development Engineer

Country of Origin: China

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: November 25th, 2024

Processing Time: 1 month, 17 days (Premium Processing Requested)


Case Summary:

A product development engineer specializing in medical devices sought our assistance in applying for a National Interest Waiver (NIW) to advance her research in the United States. Understanding the complexity of the process, we made sure to provide her expert guidance to ensure a smooth approval.

When preparing her personalized petition, we emphasized her M.S. in Mechanical Engineering to demonstrate that she is well-qualified to pursue her proposed work. Her research is widely recognized, with 3 peer-reviewed journal articles (1 first-authored), 1 abstract, and 2 peer-reviewed conference articles (1 first-authored), all published in top journals. Her publications have been cited 51 times according to Google Scholar, further confirming her recognition in the field.

Her work focuses on developing implants using advanced medical image processing methods for patients with unique physiological needs. This research has significant national importance as it enhances American leadership in medical innovation and improves patient care.

Due to its clear national importance, our client’s research has been supported with funding from the National Institutes of Health (NIH). This funding is reserved solely for research directed at advancing the national interest, particularly studies aimed at improving health and reducing illness and disability.

She received 3 strong recommendation letters from respected experts in the field, further strengthening her case. One of the letters included the following statement:

“Considering the value presented by enhanced diagnostic accuracy and the development of cost-effective diagnostic tools, halting [Client’s] research would be damaging to healthcare innovation and technological advancement. It is, therefore, within the interests of the U.S. to allow [Client’s] research to continue, ensuring ongoing improvements in medical imaging that support critical healthcare improvements and contribute to national competitiveness in technology and healthcare sectors.”

Thanks to our team’s comprehensive documentation and premium processing, she secured her NIW approval in 47 days only. We are grateful for her trust in us and wish her continued success in her research.